| Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases (NCT05812534) | Second Affiliated Hospital of Nanchang University | 2023-12-01 |
| Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test (NCT06188104) | Department of Medical Services Ministry of Public Health of Thailand | 2023-11-30 |
| Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer (NCT06134765) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-11-30 |
| Study of INKmune in Patients With mCRPC (CaRe Prostate) (NCT06056791) | Inmune Bio, Inc. | 2023-11-30 |
| Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma (NCT06415708) | Institute of Hematology & Blood Diseases Hospital, China | 2023-11-30 |
| Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC (NCT06132698) | West China Hospital | 2023-11-30 |
| Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult (NCT06099613) | EyeGene Inc. | 2023-11-30 |
| Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency (NCT03733067) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-11-30 |
| A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema (NCT06181227) | Aviceda Therapeutics, Inc. | 2023-11-30 |
| Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma (NCT05004064) | University College, London | 2023-11-30 |
| Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases (NCT06152822) | Tongji Hospital | 2023-11-30 |
| The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial. (NCT06140576) | Zhejiang Cancer Hospital | 2023-11-30 |
| Refractory Chronic Cough Improvement Via NAL ER (RIVER) (NCT05962151) | Trevi Therapeutics | 2023-11-30 |
| Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma (NCT06066359) | M.D. Anderson Cancer Center | 2023-11-30 |
| A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes (NCT06046417) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2023-11-30 |
| Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast (NCT06129747) | Case Comprehensive Cancer Center | 2023-11-30 |
| Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS). (NCT05997277) | Beth Israel Deaconess Medical Center | 2023-11-30 |
| EGCG for the Prevention and Treatment of TIPN (NCT06524609) | Han Xi Zhao | 2023-11-30 |
| Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases. (NCT06143722) | West China Hospital | 2023-11-30 |
| Qarziba for Patients in Relapsed/Refractory High-grade Osteosarcoma (NCT05558280) | Prof. Franca Fagioli | 2023-11-30 |
| Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis (NCT05725057) | Artax Biopharma Inc | 2023-11-30 |
| Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer (NCT05872204) | Universitaire Ziekenhuizen KU Leuven | 2023-11-30 |
| Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma (NCT06876688) | Ruijin Hospital | 2023-11-30 |
| A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia). (NCT05927012) | Keros Therapeutics, Inc. | 2023-11-30 |
| Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer (NCT05954143) | Bolt Biotherapeutics, Inc. | 2023-11-30 |
| Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma (NCT06124001) | CNBG-Virogin Biotech (Shanghai) Ltd. | 2023-11-30 |
| Durvalumab and Oleclumab in Resectable PDAC (NCT06060405) | University Health Network, Toronto | 2023-11-29 |
| A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD) (NCT06128564) | Hoffmann-La Roche | 2023-11-29 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis (NCT06166056) | Chiesi Farmaceutici S.p.A. | 2023-11-29 |
| Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease (NCT05896670) | Oculis | 2023-11-29 |
| Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia (NCT06179108) | LB Pharmaceuticals Inc. | 2023-11-29 |
| Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU) (NCT06162728) | Jasper Therapeutics, Inc. | 2023-11-29 |
| Study of ODX (OsteoDex) in Multiple Myeloma (NCT06616389) | DexTech Medical AB | 2023-11-29 |
| CERebrolysin In CADASIL (NCT05755997) | Ever Neuro Pharma GmbH | 2023-11-29 |
| Investigation of Laser Assisted Drug Delivery of NanoDOX® (NCT05411484) | Massachusetts General Hospital | 2023-11-29 |
| Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome (NCT06203457) | argenx | 2023-11-29 |
| Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC (NCT05762536) | Erasmus Medical Center | 2023-11-29 |
| Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma (NCT05830058) | City of Hope Medical Center | 2023-11-29 |
| Autologous TLPO Vaccine Basket (NCT06175221) | Elios Therapeutics, LLC | 2023-11-29 |
| Feasibility and Efficacy Study for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery (NCT06227585) | Alume Biosciences, Inc. | 2023-11-29 |
| A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) (NCT06203002) | Lexicon Pharmaceuticals | 2023-11-29 |
| Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency (NCT05907746) | National Cancer Institute (NCI) | 2023-11-29 |
| Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2) (NCT05974267) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2023-11-28 |
| Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke (NCT05728333) | Xinqiao Hospital of Chongqing | 2023-11-28 |
| DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer (NCT06178159) | RemeGen Co., Ltd. | 2023-11-28 |
| Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL) (NCT06347653) | Peking University | 2023-11-28 |
| Role of CBD in Improving Alexithymia (NCT05832281) | University of California, San Diego | 2023-11-28 |
| Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer (NCT06199895) | Liu Huang | 2023-11-28 |
| Comparison of Microneedling and CTG for Gingival Augmentation- A RCT (NCT06060119) | Krishnadevaraya College of Dental Sciences & Hospital | 2023-11-28 |
| Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma (NCT06046482) | M.D. Anderson Cancer Center | 2023-11-28 |
| A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia (NCT06185673) | Benitec Biopharma, Inc. | 2023-11-28 |
| A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa. (NCT06022159) | Institut Claudius Regaud | 2023-11-28 |
| Superficial Cervical Plexus Block and Quality of Recovery After Thyroidectomy (NCT06002152) | Yale University | 2023-11-27 |
| A Study of Ultra High Dose Diuretics to Treat Heart Failure (NCT06036914) | Mayo Clinic | 2023-11-27 |
| A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) (NCT06094296) | Bristol-Myers Squibb | 2023-11-27 |
| Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma. (NCT06155383) | RemeGen Co., Ltd. | 2023-11-27 |
| AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma (NCT05985694) | Advagene Biopharma Co. Ltd. | 2023-11-27 |
| Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia (NCT05653440) | University of Pittsburgh | 2023-11-27 |
| Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment (NCT06041152) | Centre for Addiction and Mental Health | 2023-11-27 |
| A Study to Evaluate Setanaxib in Patients With Alport Syndrome (NCT06274489) | Calliditas Therapeutics AB | 2023-11-27 |
| A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007) (NCT06113328) | Merck Sharp & Dohme LLC | 2023-11-27 |
| Human Dental Pulp Mesenchymal Stem Cells for the Treatment of Chronic Periodontitis Patients (NCT05924373) | Peking University Third Hospital | 2023-11-27 |
| Evaluating Smoking Cessation Interventions for PWH in South Africa (NCT05413122) | Johns Hopkins University | 2023-11-27 |
| A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis (NCT06679153) | VivaVision Biotech, Inc | 2023-11-27 |
| Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy (NCT06029595) | Chiesi Farmaceutici S.p.A. | 2023-11-26 |
| Phase 2 Study of TXA127 in Post-ischemic Stroke Patients (NCT06135103) | Constant Therapeutics LLC | 2023-11-26 |
| Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study (NCT06016387) | Sunnybrook Health Sciences Centre | 2023-11-25 |
| Comparative Efficacy of Xiaopi Granules and Decoction in Triple-negative Breast Cancer: a Randomized Controlled Trial (NCT06154109) | Zhiyu Wang | 2023-11-25 |
| Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome (NCT06142656) | October 6 University | 2023-11-25 |
| A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma. (NCT06130007) | Xuekui Liu | 2023-11-25 |
| Influenza Viral Challenge Study of CC-42344 in Healthy Participants (NCT06160531) | Cocrystal Pharma, Inc. | 2023-11-25 |
| HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease (NCT05865990) | MedSIR | 2023-11-24 |
| Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions (NCT06065046) | Tang-Du Hospital | 2023-11-24 |
| Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL (NCT05694312) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2023-11-24 |
| Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. (NCT05948943) | Novartis Pharmaceuticals | 2023-11-24 |
| Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML (NCT06133556) | Institute of Hematology & Blood Diseases Hospital, China | 2023-11-24 |
| Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis (NCT05556746) | Brigham and Women's Hospital | 2023-11-24 |
| Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic (NCT06109831) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2023-11-24 |
| Small Bites Vs Large Bites Abdominal Midline Incisional Closure (NCT07154277) | Dow University of Health Sciences | 2023-11-23 |
| Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis (NCT06058546) | Tasly Pharmaceutical Group Co., Ltd | 2023-11-23 |
| Dose Escalation For INtraprostatic LEsions (NCT05851547) | Ottawa Hospital Research Institute | 2023-11-23 |
| Efficacy and Safety Study of Moxidectin in Adults With Scabies (NCT05875441) | Medicines Development for Global Health | 2023-11-23 |
| Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS (NCT06189833) | Stichting European Myeloma Network | 2023-11-23 |
| Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration (NCT05893225) | University Hospital, Antwerp | 2023-11-23 |
| Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes (NCT06282978) | PETHEMA Foundation | 2023-11-23 |
| AZA Combined With RCHOP in P53-mutated DLBCL. (NCT06158399) | The First Affiliated Hospital of Xiamen University | 2023-11-22 |
| Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients (NCT05558007) | Biozeus Biopharmaceutical S.A. | 2023-11-22 |
| Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL (NCT06151080) | The First Affiliated Hospital of Xiamen University | 2023-11-22 |
| Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma (NCT06158386) | The First Affiliated Hospital of Xiamen University | 2023-11-22 |
| Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis (NCT05942911) | Incannex Healthcare Ltd | 2023-11-22 |
| All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma (NCT06158412) | The First Affiliated Hospital of Xiamen University | 2023-11-22 |
| NBMI Treatment in Patients With Mercury Toxicity (NCT04183595) | EmeraMed | 2023-11-22 |
| BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer (NCT06085742) | University of Illinois at Chicago | 2023-11-22 |
| Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma (NCT06151106) | The First Affiliated Hospital of Xiamen University | 2023-11-22 |
| Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome (NCT06198842) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2023-11-22 |
| A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury (NCT06091020) | Merz Therapeutics GmbH | 2023-11-22 |
| A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM (NCT06199505) | Gan and Lee Pharmaceuticals, USA | 2023-11-21 |
| PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity (NCT06199427) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2023-11-21 |
| Short-course Regimens for the Treatment of Pulmonary Tuberculosis (NCT05766267) | Centers for Disease Control and Prevention | 2023-11-21 |
| Randomized Placebo Controlled Study of Triamcinolone Acetonide Extended Release Injection for Thumb (CMC) Osteoarthritis (NCT06237153) | Marie Badalamente | 2023-11-21 |